• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume9, Issue1

Comparison of IV dexmedetomidine & propofol versus IV dexmedetomidine & ketamine for daycare urological procedures: a randomized controlled study

    Dr. Suresh Janapati,Dr. Kiran Kumar Suggala, Dr. DasariSamyuktha

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 964-972

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Most urologic surgeries are performed in a narrow, limited space with
minimally invasive technique or cystoscope& anaesthesia for these procedures is
administered with the goals of safety, satisfactory procedural condition for the performance
of therapeutic or diagnostic procedures ensuring rapid recovery with minimal post-operative
complications. Therefore, we decided to compare the efficacy & safety of IV Propofol @1.5
mg/kg +Dexmedetomidine @1μg/kg versus IV Ketamine @ 1mg/kg + Dexmedetomidine @
1μg/kg in providing procedural sedation in urological procedures.
Material & Methods: This prospective randomized study was conducted in Department of
Anaesthesiology of Mamata medical hospital. In this study 50 patients scheduled for elective
daycare urological procedures were included and divided equally in two groups. Group Areceived
IV Propofol 1.5 mg/kg, then infusion of Dexmedetomidine@ 1μg/kgand group Breceived
IV Ketamine 1mg/kg, then Dexmedetomidine@ 1μg/kg.
Results: In our study, there is no significant difference in age, weight, gender. The
comparison of mean between two groups after giving dexmedetomidine was statistically
significant (p< 0.05) in heart rate, SBP, onset, duration of analgesia, VAS & Ramsay scores
but DBP & SpO2 was statistically not significant.
Conclusion: Comparison of baseline & intraoperative hemodynamics, showed that the values
were better maintained in Dexmedetomidine + propofol (Group-A) than Dexmedetomidine +
Ketamine (Group B). We have concluded that Dexmedetomidine + Propofol combination was
superior to Dexmedetomidine + Ketamine, providing early onset of sedation, prolonged
analgesia & stable intraoperative hemodynamics.
Keywords:
    Dexmedetomidine Propofol Ketamine urological procedures
  • PDF (610 K)
  • XML
(2022). Comparison of IV dexmedetomidine & propofol versus IV dexmedetomidine & ketamine for daycare urological procedures: a randomized controlled study. European Journal of Molecular & Clinical Medicine, 9(1), 964-972.
Dr. Suresh Janapati,Dr. Kiran Kumar Suggala, Dr. DasariSamyuktha. "Comparison of IV dexmedetomidine & propofol versus IV dexmedetomidine & ketamine for daycare urological procedures: a randomized controlled study". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 964-972.
(2022). 'Comparison of IV dexmedetomidine & propofol versus IV dexmedetomidine & ketamine for daycare urological procedures: a randomized controlled study', European Journal of Molecular & Clinical Medicine, 9(1), pp. 964-972.
Comparison of IV dexmedetomidine & propofol versus IV dexmedetomidine & ketamine for daycare urological procedures: a randomized controlled study. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 964-972.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 80
  • PDF Download: 89
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus